03.05.2022

Evaluate report signals orphan drug market is niche no more

Leading provider of market intelligence and predictive analytics for the pharmaceutical industry, Evaluate, has released the findings of its 2022 Orphan Drug Report, which shows that the orphan drug market is growing more than twice as fast as the non-orphan pharmaceuticals market.

---